Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NVSEF - FSD Pharma Jumps On COVID-19 Trial Progress And Other News: The Good Bad And Ugly Of Biopharma


NVSEF - FSD Pharma Jumps On COVID-19 Trial Progress And Other News: The Good Bad And Ugly Of Biopharma

FSD Pharma Stock Jumps on FDA Nod for COVID 19 Trial

FSD Pharma Inc. (HUGE) announced that the FDA has provided its approval to the company for the design of its COVID-19 trial. The approval now allows the company to submit an Investigational New Drug Application for using its drug candidate FDS-201 for treating COVID-19 patients. The drug candidate aims to control the cytokine storm related to the acute lung injury in hospitalized COVID-19 patients.

The trial is expected to be a randomized, controlled and double-blind multi-center study. The main aim of the

Read more ...

Stock Information

Company Name: Novartis Ag Basel Akt
Stock Symbol: NVSEF
Market: OTC
Website: novartis.com

Menu

NVSEF NVSEF Quote NVSEF Short NVSEF News NVSEF Articles NVSEF Message Board
Get NVSEF Alerts

News, Short Squeeze, Breakout and More Instantly...